Ask the Expert Answers
Q&A: Dr. Anna Podolanczuk, MD
Dr. Podolanczuk is the Co-Director of the Weill Cornell Interstitial Lung Disease Program The following questions were submitted from Three Lakes 12-20 subscribers and followers as a part of our Ask the Expert series, where we provide a forum to industry professionals to widen access and education from those who are actively working towards the treatment and future of pulmonary fibrosis. The existing drugs are antifibrotics, and slow disease but do not stop progression. In terms of stopping...
Q&A: Dr. Andy Limper, MD
Dr. Limper is the Head of the Thoracic Research Unit at the Mayo Clinic in Rochester, Minnesota. The following questions were submitted from Three Lakes 12-20 subscribers and followers as a part of our Ask the Expert series , where we provide a forum to industry professionals to widen access and education from those who are actively working towards the treatment and future of pulmonary fibrosis. How does sleep apnea affect PF? Patients with idiopathic pulmonary fibrosis have a variety of...
Meet Our Expert
Dr. Naftali Kaminski, MD
Dr. Kaminski is the Boehringer-Ingelheim Endowed Professor of Internal Medicine and Chief of Pulmonary, Critical Care and Sleep Medicine, at Yale School of Medicine
We will accept submissions for Ask the Expert with Dr. Kaminski through April 10th, 2026.
Answers will be published here on our website, so check back and stay subscribed to our email newsletter to stay updated!
Submit Your Questions
Ask the Expert
Advancing our mission means involving the scientific and industry professionals who are closest to the patients, research, and development opportunities.
In our Ask the Expert series, we will provide a form to submit questions to an identified Expert related to pulmonary fibrosis. Each month, we will introduce a new Expert.
Submit your questions, subscribe to our email list, and stay in touch to hear answers directly from our Expert!